Harleysville, Pennsylvania, USA, 24th January 2024: Colorcon, a world leader in the development and supply of film coating systems, speciality excipients and functional packaging for the healthcare industries, announces the launch of a new Opadry® titanium dioxide (TiO2)-free film coating system for pharmaceutical tablets.

Annabel Bordmann, Film Coatings General Manager explains, “With uncertainty around the future of TiO2 use in pharmaceutical products marketed in the European Union, global pharmaceutical manufacturers are interested to formulate their products without the inclusion of TiO2. During the past 5 years, Colorcon scientists have been developing a portfolio of Ti02-free film coating products for different functionalities. This new formulation is not only TiO2-free but provides PVA-based coating benefits and good opacity at standard weight gain.”

Dr Ali Rajabi-Siahboomi, Chief Innovation Officer adds, “With Colorcon’s in-depth knowledge of materials, coating technology and regulatory needs, this new Ti02-free formulation is designed to provide the PVA-based film coating properties such as; great adhesion, easy and fast processing times combined with moisture protection, that formulators have appreciated for many years.”

Through its extensive portfolio of Opadry® complete film coating systems, Colorcon helps customers reduce complexity and time-to-market by delivering high-quality products, with ingredients carefully selected to meet local pharmaceutical regulatory requirements. This is all backed by Colorcon’s superior and dedicated technical support, along with regulatory expertise.